BR9710175A - Métodos para determinar a presença da protéina s-100 do cérebro. - Google Patents

Métodos para determinar a presença da protéina s-100 do cérebro.

Info

Publication number
BR9710175A
BR9710175A BR9710175-3A BR9710175A BR9710175A BR 9710175 A BR9710175 A BR 9710175A BR 9710175 A BR9710175 A BR 9710175A BR 9710175 A BR9710175 A BR 9710175A
Authority
BR
Brazil
Prior art keywords
brain
protein
methods
thr82
glu93
Prior art date
Application number
BR9710175-3A
Other languages
English (en)
Inventor
Jan Brundell
Lena Nyberg
Original Assignee
Sangtec Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangtec Medical Ab filed Critical Sangtec Medical Ab
Publication of BR9710175A publication Critical patent/BR9710175A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"MéTODOS PARA DETERMINAR A PRESENçA DA PROTEìNA S-100 DO CéREBRO". Proporciona-se método de ensaio para determinar a presença da proteína S-100 do cérebro em uma amostra clínica que usa anticorpos direcionados a epítopos na região entre ser1 e asn38 e entre tre82 e glu93 da seq³ência de aminoácidos da subunidade <225> da S100B humana.
BR9710175-3A 1996-07-05 1997-06-27 Métodos para determinar a presença da protéina s-100 do cérebro. BR9710175A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602677A SE9602677D0 (sv) 1996-07-05 1996-07-05 Methods for determining brain antigens
PCT/SE1997/001164 WO1998001471A1 (en) 1996-07-05 1997-06-27 Methods for determining the presence of brain protein s-100

Publications (1)

Publication Number Publication Date
BR9710175A true BR9710175A (pt) 2000-01-11

Family

ID=20403304

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710175-3A BR9710175A (pt) 1996-07-05 1997-06-27 Métodos para determinar a presença da protéina s-100 do cérebro.

Country Status (13)

Country Link
EP (1) EP0931094B1 (pt)
JP (1) JP2000515854A (pt)
AT (1) ATE301671T1 (pt)
AU (1) AU715797B2 (pt)
BR (1) BR9710175A (pt)
CA (1) CA2259413A1 (pt)
DE (1) DE69733957T2 (pt)
ES (1) ES2247633T3 (pt)
IL (1) IL127278A0 (pt)
NO (1) NO986218L (pt)
NZ (1) NZ333408A (pt)
SE (1) SE9602677D0 (pt)
WO (1) WO1998001471A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE324380T1 (de) * 1998-08-28 2006-05-15 Canag Diagnostics Ab Monoklonale antikörper gegen s100
JP4820003B2 (ja) * 1998-11-05 2011-11-24 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 癌の血清マーカーとしてのｓ１００タンパク質および自己抗体
US6780606B1 (en) 1999-02-26 2004-08-24 Synx Pharma, Inc. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
EP1216417A1 (de) * 1999-09-28 2002-06-26 Evotec OAI AG Quantitative analyse und typisierung subzellulärer partikel
WO2001096878A2 (en) * 2000-06-14 2001-12-20 University Of Zurich Marker for neurodegerative diseases and its use in drug screening
ES2394972B2 (es) * 2011-06-17 2013-07-19 Universidade De Santiago De Compostela Péptido antigénico aislado derivado de la proteína s100-beta, procedimiento de identificación y su uso en la prevención, tratamiento, diagnóstico y/o seguimiento de la diabetes tipo i.
ES2394331B2 (es) * 2011-06-17 2013-07-15 Universidade De Santiago De Compostela Uso de un péptido antigénico aislado derivado de la proteína s100-beta no unido a una molécula mhc de clase ii en la prevención, tratamiento, diagnóstico y/o seguimiento de la diabetes tipo i
CN102331502B (zh) * 2011-08-31 2013-12-04 内蒙古科慧生物科技有限责任公司 人s100蛋白(s-100)定量测定试剂盒
US20150141528A1 (en) * 2013-05-31 2015-05-21 Banyan Biomarkers, Inc. Neural specific s100b for biomarker assays and devices for detection of a neurological condition
CN111487409A (zh) * 2019-01-28 2020-08-04 艾维可生物科技有限公司 一种s100b蛋白的化学发光法检测试剂盒及其使用方法

Also Published As

Publication number Publication date
CA2259413A1 (en) 1998-01-15
NO986218D0 (no) 1998-12-30
SE9602677D0 (sv) 1996-07-05
EP0931094A1 (en) 1999-07-28
AU715797B2 (en) 2000-02-10
JP2000515854A (ja) 2000-11-28
WO1998001471A1 (en) 1998-01-15
AU3563397A (en) 1998-02-02
EP0931094B1 (en) 2005-08-10
ATE301671T1 (de) 2005-08-15
NZ333408A (en) 1999-05-28
ES2247633T3 (es) 2006-03-01
IL127278A0 (en) 1999-09-22
DE69733957D1 (de) 2005-09-15
DE69733957T2 (de) 2006-04-13
NO986218L (no) 1998-12-30

Similar Documents

Publication Publication Date Title
Hoffman Allergens in bee venom: III. Identification of allergen B of bee venom as an acid phosphatase
DE240975T1 (de) Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen.
BR9710968A (pt) Antìgenos de célula b humana; reagentes correlatos
FI84107C (fi) HbA1c:s immunologiska bestaemningsfoerfarande som innefattar denaturering
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
NO20014584D0 (no) Proteinisolering og -analyse
KR970700772A (ko) T 세포 항원 수용체의 v 영역 단백질 및 그것의 제조 방법(t cell antigen receptor v region proteins and methods of preparation thereof)
BR9710175A (pt) Métodos para determinar a presença da protéina s-100 do cérebro.
PT100978A (pt) Peptidos recombitopos, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem e seu uso
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
PT909388E (pt) Ensaios imunologicos para encefalopatias espongiformes
EP0869177A3 (en) Human a- and b- platelet-derived growth factor receptor proteins and uses therefor.
BR9507389A (pt) Método para detectar a presença de uma espécie mycobacterium e um kit e anticorpos para uso no mesmo
BRPI0406265A (pt) Método para análise eletroforética capilar, métodos para pesquisa e tipagem de proteìnas monoclonais, processo para preparação de anticorpos modificados, anticorpos modificados, kit para detecção e tipagem de proteìnas monoclonais e uso de anticorpos
BR9713450A (pt) Quimiocinas de mamìfero
DE3787706T2 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
ATE124706T1 (de) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben.
PT88303A (pt) Processo para a fixacao de um antigene ou anticorpo e de uma proteina imunologicamente diferente de um veiculo solido
Lloyd et al. The antigenic constituents of cattle skin washings
ES8606500A1 (es) Un metodo para determinar la presencia de ige especifica en sueros humanos
DE3855007D1 (de) METHODE ZUR REINIGUNG REKOMBINANTER t-PA VON DEN IHREN ENTSPRECHENDEN WIRTSZELLPROTEINEN
DE3781808T2 (de) Diagnosetestverfahren fuer schweinedysenterie.
Xu Separation and characterization of sperm antigens using two-dimensional gel electrophoresis and immunoblotting
BR9105983A (pt) Anticorpos monoclonais que diferenciam entre proteinas de sequencias nativa e modificada
Mollova et al. Identification of functionally active boar sperm specific antigens

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: DIASORIN AB (SE)

Free format text: ALTERADO DE: AB SANGTEC MEDICAL

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI.